Background {#Sec1}
==========

Laparoscopic cholecystectomy (LC) substantially reduced the incidence of surgical complications in experienced hands \[[@CR1]\]. At present, it is the gold standard treatment for symptomatic cholecystolithiasis patients. The most common complications of LC include iatrogenic bile duct injury, postoperative bleeding, damage to adjacent structures and infections \[[@CR2]\]. Intrahepatic subcapsular hematoma (ISH) is an extremely rare complication after LC, which could be life-threatening. Till now, only very few cases have been reported, the experience to diagnose and treat ISH after LC remains largely limited \[[@CR3], [@CR4]\]. Herein, we reported a case of giant ISH after LC and reviewed all of the published cases.

Case presentation {#Sec2}
=================

The patient was a 32-year old woman with a one-year history episodes of cholecystitis treated conservatively. She did not have any other disease history. After an abdominal magnetic resonance imaging that confirmed multiple gallbladder stones (Fig. [1](#Fig1){ref-type="fig"}a), an elective LC was performed without intra-operative complications. The recovery was uneventful and the patient was discharged two days after operation. On the second day after discharge, the patient developed severe right upper abdominal pain and she was sent to our emergency department at 8:30 pm. At arrival, her heart rate was 110 bpm and the blood pressure was 80/55 mmHg. The hemoglobin dropped to 86 g/l from 127 g/l. The CT scan showed a 10.9 × 12.5 × 6.6 cm ISH in the right liver without obvious free fluid in abdominal cavity (Fig. [1](#Fig1){ref-type="fig"}b). Two hours after fluid resuscitation including 2 U red blood cell, the hemoglobin further declined to 78 g/l and the hemodynamics remained unstable. The abdominal pain was not relieved, after intravenous analgesics. A Doppler ultrasound was performed, two hours later and it found the hematoma had increased in size. Active intrahepatic bleeding was suspected. We called radiologist for consultation, however, the interventional angiography and embolization was not available at mid night. We explained the potential risk of sudden rupture of hematoma during conservative methods which may cause sudden death, to the patient and her relatives. After careful consideration of the continuous decline of hemoglobin, unstable hemodynamics after fluid resuscitation, we explained our surgical plan to the patient and her relative. We planned to perform laparoscopic exploration at first, if the hematoma continued to expand, we would evacuate or drain it, if not, we would put a drainage tube under liver which could serve as an early warning of rupture. The patient requested surgical method to reduce the risk of sudden death. Therefore, an emergency laparoscopic exploration was performed under general anesthesia. The ISH was confirmed (Fig. [1](#Fig1){ref-type="fig"}c). Four U red blood cell and 400 ml fresh frozen plasma were transfused. After fluid resuscitation and blood transfusion, her hemodynamic became stable. During the 3-h intra-operative observation, the hematoma did not expand. Therefore, a non-sucking drainage tube was placed under the liver and she was sent to ICU ward. Next morning, she was transferred to the ordinary ward. The upper abdominal pain gradually relieved. Five days after the laparoscopic exploration, another CT scan showed that the hematoma was largely resolved and we removed drain tube (Fig. [1](#Fig1){ref-type="fig"}d). She was discharged, 10 days after readmission.Fig. 1Giant ISH after LC: **a** Multiple gallbladder stones; **b** Giant ISH after LC; **c** Laparoscopic view of a giant ISH; **d** The ISH was absorbed

Totally, 13 papers, including 16 cases of ISH after LC were reported from 1994 to 2015 (Table [1](#Tab1){ref-type="table"}). Nearly half of the patients had instability of hemodynamics. All of the cases were female patients. Age of patients ranged from 25 to 78. All hematomas were mainly located in the right lobe of liver, and some of them extended to the left lobe of liver. Only one case was ruptured at diagnosis. Hepatic capsule laceration was found in two cases, one of whom also took NSAIDS (non-steroids anti-inflammatory drugs) to control the pain after operation. Totally, 58.8% of patients took NSAIDS to control the post-operative pain, and most of them used Ketorolac, however, 35.3% of the patients still did not have definitive risk factors. The time interval to diagnose ISH after LC ranged from seven hours to six weeks. They were diagnosed most commonly (35.5%) within one day after LC. All patients had abdominal pain and 47.1% of the cases developed hypovolaemic shock.Table 1Literature review of ISH after LCNo.Year of PublicationGenderAgeCausesLocation of hematomaTime interval after LCSymptomsTreatmentsOutcomes12015 \[[@CR12]\]Female25No definitive causeRight lobes of liverOne day after LChypovolaemic shockLaparotomy, hematoma evacuation13 days after laparotomy, discharged22015 \[[@CR8]\]Female60No definitive causeRight lobes of liverSix days after LCRight upper abdominal pain, nausea, feverPercutaneous drainage under ultrasound guidance18 days after readmission, discharged32012 \[[@CR3]\]Female77Coumarin (anticoagulation drug)Right lobes of liverSix weeks after LCRight upper abdominal painSelective embolization of the bleeding vessel, drainage under ultrasound guidanceRecovered uneventfully42011 \[[@CR13]\]Female25Capsule lacerationRight lobes of liver extended to left sideTwo days after LCRight upper abdominal pain, drop of HGBLaparoscopic explorationRight pleural effusion was treated with a pigtail pleural catheter; 5 days after laparoscopic exploration, discharged.52010 \[[@CR9]\]Female28Capsule laceration, NSAIDSRaptured right liver hematomaOne day after LCRight upper abdominal pain, hypotension, tachycardia, and severe anemiaLaparotomy, and hematoma evacuation, drainageDischarged without further complaints62010 \[[@CR4]\]Female60Ketorolac (NSAIDS), ultiple myelomaRight lobes of liverSix days after LCRight upper abdominal pain, hemodynamic instabilityLaparotomy, hematoma drainage and packing31 days after laparotmy, discharged72010 \[[@CR4]\]Female29Ketorolac (NSAIDS)Right lobes of liverOne day after LCPerspiration and hypotensionLaparotomy, hematoma drainage and packing30 days after laparotmy, discharged82009 \[[@CR10]\]FemaleNot availableNo definitive causeRight lobes of liverNot availableabdominal painConservative treatmentsUneventful recovery92008 \[[@CR14]\]FemaleNot availableKetorolac (NSAIDS)Raptured right liver hematomaNot availableabdominal pain, hemodynamic instabilityLaparotomy, hematoma evacuation and drainageUneventful recovery102005 \[[@CR11]\]Female61NSAIDSRight lobes of liverThree days after LCFever, upper abdominal pain,Percutaneous drainage under CT guidanceUneventful recovery112005 \[[@CR11]\]Female66NSAIDSRight lobes of liverNot mentionedFever, upper abdominal pain, nauseaConservative treatmentsUneventful recovery122004 \[[@CR15]\]Female64No definitive causeRight lobes of liverTen days after LCupper abdominal discomfort, nausea, and pyrexiaPercutaneous drainage under ultrasound guidance14 days later, discharged131998 \[[@CR16]\]Female48Ketorolac (NSAIDS)Right lobes of liverOne day after LCupper abdominal discomfort, nauseaPercutaneous drainage under ultrasound guidance, twice14 days later, discharged141998 \[[@CR16]\]Female28Ketorolac (NSAIDS)Right lobes of liverSeven hours after LCRight upper abdominal pain, hypotension, tachycardia, and severe anemiaLaparotomy, and hematoma evacuation, drainage8 days later, discharged, 3 weeks later, the drainage tube was removed151998 \[[@CR17]\]Female78No definitive causeRight lobes of liverNot availableRight upper abdominal painConservative treatmentsUnenventful recovery161994 \[[@CR18]\]Female35Ketorolac (NSAIDS)Right lobes of liverNine hours after LCTachycardia and hypotensionLaparotomy1 week after laparotomy, discharged

Treatment strategies included: conservative treatment (antibiotics, blood transfusion, strict bed-reset), percutaneous drainage under CT or B ultrasound guidance, selective embolization of the bleeding vessel, laparoscopic exploration and laparotomy. Eighteen percent of patients had stable condition without fever and underwent conservative treatments. The only case of angioembolization was complicate by infection and required percutaneous drainage. For the patients with stable condition, fever and serious compression of inferior venal cava (IVC) always were indications for percutaneous drainage under CT or B ultrasound guidance. In these 17 cases, 29.4% of the patients underwent percutaneous drainage. For the patients with hemodynamic instability, emergent reoperation was adopted. Totally, nine cases underwent reoperation, including two case of laparoscopic operation and seven cases of laparotomy. For our case, we only performed laparoscopic exploration and did not perform evacuation or drainage of the hematoma, since the hemodynamic became stable after plenty fluid resuscitation and the hematoma did not expand, during the 3 h of intra-operative observation. For another case, laparoscopic exploration found small capsule laceration, and hemostasis was performed. In the seven cases of laparotomy, six patients underwent evacuation and drainage of hematoma, only one case underwent only laparotomy without evacuation or drainage.

All patients survived. Most of patients stayed one to two weeks after readmission, however, the longest hospital stay was up to 31 days after reoperation.

Discussion and conclusion {#Sec3}
=========================

LC is a widely performed procedure for symptomatic gallbladder stone. Although the overall morbidity is less than 7%, it carries certain risks, the most common complications include infections, bile leak and postoperative bleeding \[[@CR5]\]. Postoperative bleeding after LC is observed in less than 1% of cases. The most common sites of postoperative bleeding include: gallbladder bed, sites of trocar, cystic artery, falciform ligament and bleeding from the ruptured liver capsule \[[@CR6]\]. The ISH is a rare, life-threatening complication after LC. No conclusive cause for ISH has been found. Iatrogenic liver trauma, NSAIDS, anticoagulants, hepatic haemangioma, anatomical variations of the hepatic vascular system have all been named as possible contributing factors \[[@CR4], [@CR7], [@CR8]\]. In this case, the patient took Parecoxib to control the pain. The literature review showed that 58.8% of the patients took NSAIDS to control postoperative pain, and most of them took Ketorolac. The preoperative coagulation function of this patient was normal and as well, she did not suffer no steatosis or cirrhosis which may be risk factors for ISH after minor trauma.

When the ISH is small, it is usually asymptomatic, therefore, it is very difficult to detect it at an early stage. However, when it keeps developing, it could be life-threatening, leading to hypovolaemic shock and even death. The treatment for ISH should be adopted according to the condition of the patients. When the ISH is small and the condition of patient is stable, conservative treatment is always preferred. Some other more aggressive treatments, including percutaneous B ultrasound -guided drainage, relaparotomy or relaparoscopy, evacuation or drainage of the hematoma, should be considered when the ISH is too big or the patient is hemodynamically unstable \[[@CR9]--[@CR11]\]. In all of these 17 cases, only one case was ruptured, however, 14 cases were operated, therefore, rupture may not the unique indication for surgical treatment. The most important key point for ISH is the risk of sudden death due to massive bleeding after rupture of hematoma. When the doctors explain the possibility of this lethal outcome to the patients, they always request to reduce this possibility as much as possible. This patient suffered hemodynamical instability and continuous drop of hemoglobin even if after fluid resuscitation and the hematoma became larger after her admission within 2 h. The risk of rupture did exist for this case. When we explained the risk of rupture to the patient, she rejected the conservative treatment and requested surgical methods to reduce the risk of sudden death after potential massive bleeding. Laparoscopic exploration was minimally invasive and a drainage tube under the live would show the bleeding immediately if it occurred. Therefore, we chose the emergent laparoscopic exploration. After a 3-h intraoperative observation, the ISH did not expand and her condition was stable, in the meanwhile, in consideration to the invasive trauma of debridement and uncertain outcome of drainage of ISH, we only chose to place the drain tubes as early warning for rupture. Later, it gradually resolved. Frankly speaking, if we chose conservative treatments, including further liquid resuscitation and blood transfusion, the outcome would be the same, however, no one could guarantee this satisfactory result at that time, especially when the patients did not accept the possibility of sudden death after rupture during conservative treatment. For this giant ISH, in case of rupture in absence of drainage tube for early warning, it could be difficult to detect the bleeding immediately which may cause disastrous result.

Despite LC has been widely performed and the complications of LC is relatively low in the experienced hands, some serious complications can still occur. Giant ISH is an extremely rare, life-threatening complication after LC. The experience of how to treat this kind giant ISH remains largely limited. Herein, we presented a rare case and summarized all of the previously published cases which could substantially increase our experience to treat this rare condition. The most important key point for this giant ISH is to avoid sudden death after the rupture of hematoma, luckily, according to this literature review, only one case was ruptured and no mortality was reported.
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NSAIDS
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